Mechanism, Uses, and UK Availability Retatrutide is an investigational weight loss injection that works by simultaneously activating three hormone receptors GLP-1, GIP, and glucagon making it the first triple receptor agonist of its kind in clinical development
The BALANCE Model launching May 2026 could expand access significantly but states must opt in voluntarily
The tracking layer (calories, weight) is competent but not the focus
Apply fragrance-free moisturizers immediately after bathing while skin is still damp, and consider using a humidifier in your bedroom to maintain ambient moisture, especially during winter months or in dry climates
Several once-weekly injections for weight loss are available, each working slightly differently
Others use a faster escalation with dose increases every week instead of every two weeks